Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.22 USD | +1.84% | +6.09% | +22.94% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.94% | 591M | |
+9.72% | 106B | |
+1.17% | 104B | |
+6.72% | 23.25B | |
-13.80% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.26% | 14.26B | |
+38.93% | 12.76B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- HC Wainwright Adjusts Price Target on IGM Biosciences to $22 From $45, Maintains Buy Rating